CAMBRIDGE, Mass.--(BUSINESS WIRE)--Codon Devices, Inc., the Constructive Biology Company™, today announced its expansion into Europe with the formation of Codon Devices U.K. Ltd., and the appointment of Michael Dyson, PhD, to the newly-created position of European Managing Director. “We are excited to open our new European headquarters as a major step in our global expansion plans,” said John P. Danner, President and Chief Executive Officer of Codon Devices. “As we industrialize synthetic biology and drive a new paradigm in research called Constructive Biology™, we are experiencing rapid adoption of our advanced gene synthesis and protein engineering offerings. The interest from the European marketplace is tremendous and we are looking forward to serving these customers more effectively through this new base of operations.”
